That's a significant milestone — having amyloid plaque cleared through donanemab is genuinely encouraging news! Here's what to generally expect going forward:
Ongoing Monitoring
Even after plaque is cleared, regular brain monitoring continues. Doctors watch for a side effect called ARIA, which involves brain swelling or Show Full Answer
That's a significant milestone — having amyloid plaque cleared through donanemab is genuinely encouraging news! Here's what to generally expect going forward:
Ongoing Monitoring
Even after plaque is cleared, regular brain monitoring continues. Doctors watch for a side effect called ARIA, which involves brain swelling or small bleeds visible on MRI scans.
What the Research Shows
Long-term studies suggest that people who completed donanemab treatment continued to experience slower cognitive decline over time — especially those who started treatment early. Those with early-stage disease had a 27% lower risk of progressing to the next stage of Alzheimer's. Important Things to Keep in Mind
- Donanemab is not a cure, but it may meaningfully slow progression
- Benefits appear to grow over time
- Regular follow-up appointments and MRI scans will likely continue
- Costs and logistical requirements (like IV infusions) may still be part of ongoing care
Speaking with the trial's medical team about next steps is really important, as they'll have the most personalized guidance based on individual results.
June 27
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
